Korea Joongang Daily
Korea JoongAng Daily

Korean pharma shines at global health care conference

Korean biopharma shines at J.P. Morgan Healthcare Conference amid global industry optimism.

2024-01-09

Chong Kun Dang partners with Novartis in historic $1.3 billion deal

Pharmaceutical company Chong Kun Dang has signed a $1.3 billion technology transfer agreement with Novartis for a rare genetic disease treatment.

2023-11-06